Summary

Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Liviu Klein, MD (ucsf)
Headshot of Liviu Klein
Liviu Klein

Description

Summary

OHP-II Registry is a sponsor-initiated, multi-center, observational post-approval registry.

Official Title

Sponsor-Initiated OCS Heart Perfusion (OHP-II) Registry

Details

The objective of this sponsor-initiated OHP-II Registry is to collect data on the post-transplant clinical outcomes of all donor hearts preserved and assessed on the OCS Heart System and document the performance of the OCS device in the real-world setting.

All heart transplant recipients who are transplanted with an OCS perfused donor heart are eligible for this registry. Up to 5,000 subjects will be enrolled.

All interested U.S. Heart transplant centers that use the OCS Heart System for donor heart perfusion will constitute the OHP-II Registry participating centers.

Keywords

Heart Transplant, OCS Heart, OCS Heart Transplant Recipients

Eligibility

You can join if…

  • N/A

You CAN'T join if...

  • N/A

Locations

  • University of California San Francisco accepting new patients
    San Francisco California 94143 United States
  • Stanford University accepting new patients
    Palo Alto California 94304 United States

Lead Scientist at University of California Health

  • Liviu Klein, MD (ucsf)
    My are heart failure and cardiac arrhythmias in patients with heart failure. Having advanced training in both heart failure and electrophysiology, I practice an integrated approach in treating patients with heart failure and cardiac arrhythmias. I am also interested in cardiac recovery using electrical (i.e. cardiac resynchronization) and mechanical (i.e. ventricular assist devices) therapies.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
TransMedics
ID
NCT05915299
Study Type
Observational [Patient Registry]
Participants
Expecting 5000 study participants
Last Updated